Hansen Pharmaceutical: Net profit of 220 million yuan in 2024, a year-on-year increase of 7.43%

Hansen Pharmaceutical announced that the operating revenue for 2024 is 1.004 billion yuan, a year-on-year increase of 5.12%. The net profit attributable to shareholders of the listed company is 220 million yuan, a year-on-year increase of 7.43%. The basic earnings per share is 0.4377 yuan/share, a year-on-year increase of 7.44%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital